When comparing GC patients to healthy individuals, nine proteins (ARG1, ATAD3B, CA2, HPT, IGFALS, JUP, KRT14, LBP, and MAN2A1) displayed significantly altered plasma levels. This evidence concerns the gene MRS2 and gastric cancer.